Contamination of dried blood spots - an underestimated risk in newborn screening
- PMID: 28763295
- DOI: 10.1515/cclm-2017-0270
Contamination of dried blood spots - an underestimated risk in newborn screening
Abstract
Background: Newborn screening (NBS) is an established screening procedure in many countries worldwide, aiming at the early detection of inborn errors of metabolism. For decades, dried blood spots have been the standard specimen for NBS. The procedure of blood collection is well described and standardized and includes many critical pre-analytical steps. We examined the impact of contamination of some anticipated common substances on NBS results obtained from dry spot samples. This possible pre-analytical source of uncertainty has been poorly examined in the past.
Methods: Capillary blood was obtained from 15 adult volunteers and applied to 10 screening filter papers per volunteer. Nine filter papers were contaminated without visible trace. The contaminants were baby diaper rash cream, baby wet wipes, disinfectant, liquid infant formula, liquid infant formula hypoallergenic (HA), ultrasonic gel, breast milk, feces, and urine. The differences between control and contaminated samples were evaluated for 45 NBS quantities. We estimated if the contaminations might lead to false-positive NBS results.
Results: Eight of nine investigated contaminants significantly altered NBS analyte concentrations and potentially caused false-positive screening outcomes. A contamination with feces was most influential, affecting 24 of 45 tested analytes followed by liquid infant formula (HA) and urine, affecting 19 and 13 of 45 analytes, respectively.
Conclusions: A contamination of filter paper samples can have a substantial effect on the NBS results. Our results underline the importance of good pre-analytical training to make the staff aware of the threat and ensure reliable screening results.
Keywords: contamination; dried blood spots; filter paper; newborn screening.
Similar articles
-
Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit.J Med Screen. 2016 Mar;23(1):7-16. doi: 10.1177/0969141315593571. Epub 2015 Jun 25. J Med Screen. 2016. PMID: 26113437
-
The use of mass spectrometry to analyze dried blood spots.Mass Spectrom Rev. 2016 May-Jun;35(3):361-438. doi: 10.1002/mas.21441. Epub 2014 Sep 22. Mass Spectrom Rev. 2016. PMID: 25252132 Review.
-
EDTA in dried blood spots leads to false results in neonatal endocrinologic screening.Clin Chem. 2008 Mar;54(3):602-5. doi: 10.1373/clinchem.2007.096685. Clin Chem. 2008. PMID: 18310148
-
Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.Mol Genet Metab. 2017 Nov;122(3):67-75. doi: 10.1016/j.ymgme.2017.07.011. Epub 2017 Jul 31. Mol Genet Metab. 2017. PMID: 28801073
-
Newborn Screening Samples for Diabetes Research: An Underused Resource.Cells. 2020 Oct 15;9(10):2299. doi: 10.3390/cells9102299. Cells. 2020. PMID: 33076340 Free PMC article. Review.
Cited by
-
Enhancing specimen collection skills for dried blood spots through an immersive virtual learning environment: a cross-sectional study.BMC Res Notes. 2024 Jan 4;17(1):16. doi: 10.1186/s13104-023-06584-9. BMC Res Notes. 2024. PMID: 38178164 Free PMC article.
-
Use of Dried Blood Spot Specimens to Monitor Patients with Inherited Metabolic Disorders.Int J Neonatal Screen. 2020 Mar 26;6(2):26. doi: 10.3390/ijns6020026. eCollection 2020 Jun. Int J Neonatal Screen. 2020. PMID: 33073023 Free PMC article. Review.
-
Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories.Int J Neonatal Screen. 2024 Sep 5;10(3):60. doi: 10.3390/ijns10030060. Int J Neonatal Screen. 2024. PMID: 39311362 Free PMC article.
-
Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy.PLoS One. 2024 Jun 28;19(6):e0306329. doi: 10.1371/journal.pone.0306329. eCollection 2024. PLoS One. 2024. PMID: 38941330 Free PMC article.
-
Metabolomics technology and bioinformatics for precision medicine.Brief Bioinform. 2019 Nov 27;20(6):1957-1971. doi: 10.1093/bib/bbx170. Brief Bioinform. 2019. PMID: 29304189 Free PMC article. Review.
References
-
- Therrell BL, Padilla CD, Loeber JG, Kneisser I, Saadallah A, Borrajo GJ, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol 2015;39:171–87.
-
- Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338–43.
-
- George RS, Moat SJ. Effect of dried blood spot quality on newborn screening analyte concentrations and recommendations for minimum acceptance criteria for sample analysis. Clin Chem 2016;62:466–75.
-
- Karaceper MD, Chakraborty P, Coyle D, Wilson K, Kronick JB, Hawken S, et al. The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Orphanet J Rare Dis 2016;11:12.
-
- Tarini BA, Clark SJ, Pilli S, Dombkowski KJ, Korzeniewski SJ, Gebremariam A, et al. False-positive newborn screening result and future health care use in a state Medicaid cohort. Pediatrics 2011;128:715–22.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous